Eric Valeur

Eric Valeur is an accomplished pharmaceutical leader currently serving as Vice President of Research and Head of Drug Discovery at Roivant Sciences since February 2021. With a robust background in drug discovery and development, Valeur has spearheaded initiatives across various scientific disciplines to deliver breakthroughs on complex targets. Formerly, Valeur held positions such as Head of Platform Research at Flagship VentureLabs, where a start-up company was established, and Director of New Modalities & Innovation at AstraZeneca, overseeing a significant transformation project in drug discovery. Recognized for exceptional contributions, Valeur has received awards for innovation and strategic development throughout a career that includes leadership roles at Novartis and Merck Serono, alongside involvement in prestigious fellowship programs. Educational credentials include a Ph.D. in Organic Chemistry from The University of Edinburgh, an MBA from Imperial College Business School, and multiple master's degrees in Chemical Engineering and Chemistry from established institutions.